Grow Your Pharma Business Digitally
Virtual Booth
Contact Supplier
Product Reset all filters
01 1Equfina
Safinamide
Eisai
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 31
2022 Revenue in Millions : 35
Growth (%) : -2
Portfolio PDF
Product Web Link
Digital Content
Website
Corporate PDF